Corey Davis, J.D., M.S.P.H., serves as Director of the Network’s Harm Reduction Legal Project, which works to address the legal and policy barriers that impede the establishment and expansion of evidence-based harm reduction measures such as naloxone distribution, syringe access programs, and access to evidence-based substance use disorder treatment. Corey and his team provide guidance and consultation in navigating the often extremely confusing maze of existing laws and regulations that hamper harm reduction initiatives.
Corey was previously a Senior Attorney at the National Health Law Program (NHeLP), where he helped to advance access to quality health care for low-income and underserved individuals. Before joining NHeLP Corey served as Employment Rights Attorney at Equality Advocates Pennsylvania, where he represented lesbian, gay, bisexual and transgender (LGBT) individuals before administrative commissions and in state and federal courts. He previously oversaw a street-based legal clinic sited at Philadelphia’s syringe exchange program.
Corey has served as chair of a county board of health, chair of the board of the North Carolina Harm Reduction Coalition, and vice-chair of the North Carolina Harm Public Health Foundation, among other positions. He is a recipient of the International AIDS Society’s Young Investigator Award and has published extensively in the lay and academic press. Corey received his B.S. from the Indiana University of Pennsylvania, his M.S.P.H. from the University of North Carolina at Chapel Hill and his J.D. from Temple University. Corey is barred in Pennsylvania and New Jersey as well as various federal courts.
This report briefly explains and contrasts the specifics of fatal overdose review panels in the six states that have established such panels as of late 2017.
The number of Americans affected by the opioid epidemic has reached staggering rates. In 2016, more Americans died from drug overdoses than died through the entirety of the Vietnam War. Fortunately, there is an effective, evidence-based way of treating opioid use disorder (OUD) – treatment with the medications methadone and buprenorphine, which is termed medication-assisted treatment (MAT).
Nearly 4.7 million Americans, including 1.3 million new enrollees, signed up for health care through the Affordable Care Act’s marketplaces, and polling indicates the public has a favorable opinion of the law. Nevertheless, after failing in their full-scale attempt to repeal and replace the Affordable Care Act (ACA), Congressional Republicans and the Trump Administration continue to put individual pieces of the legislation at risk of elimination.
This resource provides a description of the laws and regulations governing reporting of overdoses in the jurisdictions that require or explicitly permit it.
The opioid overdose epidemic is a continuing public health crisis. When we began tracking laws aimed to increase access to naloxone in late 2012, they existed in only eight states. As of July 1, 2017, every state and Washington D.C. has passed at least one law increasing access to naloxone—a remarkably rapid progression for public health legislation.
The recently released Journal of Law, Medicine & Ethics supplemental issue features articles authored by presenters at the Public Health Law Conference in Washington D.C. Corey Davis, deputy director at the Network for Public Health Law – Southeastern Region Office, co-authored the article, “Action, Not Rhetoric, Needed to Reverse the Opioid Overdose Epidemic.” In the following Q&A, Corey discusses his article and how it addresses a critical public health issue.
In response to the public health risks posed by expired and leftover medicines, federal law was enacted to encourage the establishment of voluntary drug take-back programs. This resource provides an overview of these programs.
In 2015, 33,091 Americans died of accidental opioid overdose, that’s more deaths than from car crashes or guns. Early interventions to prevent and treat substance use disorder and opioid use disorder, save lives and resources. Although access to evidence-based prevention and treatment remains far below where it should be, Medicaid and the Affordable Care Act have been instrumental in improving it.
In Colorado, 899 people died of drug-related overdoses in 2014 -- most of these deaths were caused by opioids. This fact sheet provides an overview of Colorado's law to increase access to naloxone, an opioid overdose antidote.
A public health professional contacted the Network to ask if the Network could provide them with data use agreement templates for use by local public health authorities?
With the signing of the South Carolina Overdose Prevention Act on June 3, 2014, the state made it more likely that naloxone will be available when and where it is needed. This fact sheet explains the provisions of the Overdose Prevention Act.
This fact sheet provides information on Pennsylvania's Act 139, which provides limited immunity to overdose victims and bystanders that seek medical help, and increases accesss to naloxone, a drug that can reverse the effects of an opioid overdose.
